X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gadoterate meglumine (59) 59
index medicus (52) 52
radiology, nuclear medicine & medical imaging (45) 45
humans (43) 43
gadolinium (33) 33
female (32) 32
nephrogenic systemic fibrosis (31) 31
magnetic resonance imaging (30) 30
male (30) 30
gadobenate dimeglumine (29) 29
gadopentetate dimeglumine (27) 27
gadobutrol (25) 25
contrast media (24) 24
middle aged (23) 23
contrast agents (22) 22
magnetic resonance imaging - methods (21) 21
contrast media - administration & dosage (19) 19
contrast media - adverse effects (19) 19
dentate nucleus (19) 19
gadodiamide (19) 19
adult (17) 17
aged (16) 16
animals (16) 16
globus-pallidus (16) 16
organometallic compounds - adverse effects (15) 15
meglumine - administration & dosage (14) 14
organometallic compounds - administration & dosage (14) 14
meglumine - adverse effects (13) 13
image enhancement - methods (12) 12
medicine & public health (11) 11
adolescent (10) 10
aged, 80 and over (10) 10
gadolinium-based contrast agents (10) 10
meglumine - analogs & derivatives (10) 10
reproducibility of results (10) 10
sensitivity and specificity (10) 10
brain (9) 9
gadolinium - adverse effects (9) 9
gadoteridol (9) 9
rats (9) 9
angiography (8) 8
contrast media - pharmacokinetics (8) 8
mri (8) 8
organometallic compounds (8) 8
original (8) 8
chelates (7) 7
child (7) 7
comparative analysis (7) 7
deposition (7) 7
gadoterate (7) 7
imaging / radiology (7) 7
internal medicine (7) 7
media (7) 7
nuclear magnetic resonance--nmr (7) 7
organometallic compounds - pharmacokinetics (7) 7
patients (7) 7
risk factors (7) 7
safety (7) 7
stability (7) 7
3 t (6) 6
92943-93-6 (6) 6
analysis (6) 6
child, preschool (6) 6
deep cerebellar nuclei (6) 6
diagnostic radiology (6) 6
disease models, animal (6) 6
dotarem (6) 6
gadofosveset (6) 6
gadoversetamide (6) 6
image quality (6) 6
infant (6) 6
interventional radiology (6) 6
magnetic resonance angiography (6) 6
meglumine (6) 6
neuroradiology (6) 6
prospective studies (6) 6
research (6) 6
retrospective studies (6) 6
signal intensity (6) 6
t1-weighted mr-images (6) 6
ultrasound (6) 6
usage (6) 6
allergy (5) 5
contrast enhancement (5) 5
diagnosis (5) 5
digital-subtraction-angiography (5) 5
dose-response relationship, drug (5) 5
fibrosis (5) 5
gadolinium dtpa - administration & dosage (5) 5
gadolinium dtpa - pharmacokinetics (5) 5
gadolinium pentetate (5) 5
gadolinium pentetate meglumine (5) 5
gadoterate-meglumine (5) 5
gadoteric acid (5) 5
gadoxetic acid (5) 5
kontrastmittel (5) 5
magnetic resonance angiography - methods (5) 5
magnetic-resonance angiography (5) 5
medical imaging (5) 5
nephrogenic fibrosing dermopathy - chemically induced (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Magnetic Resonance Imaging, ISSN 1053-1807, 04/2017, Volume 45, Issue 4, pp. 988 - 997
Purpose To investigate the safety of gadoterate meglumine and identify the incidence of nephrogenic systemic fibrosis (NSF). Materials and Methods An... 
adverse event | magnetic resonance imaging | gadolinium‐based contrast agent | gadoterate meglumine | gadoteric acid | contrast media | gadolinium-based contrast agent | DIAGNOSTIC-VALUE | RISK-FACTORS | ACID | EFFICACY | CONTRAST AGENTS | MRI | GUIDELINES | GD-DOTA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SEVERITY | NEPHROGENIC SYSTEMIC FIBROSIS | Prospective Studies | Follow-Up Studies | Image Enhancement | Humans | Middle Aged | Child, Preschool | Infant | Male | Incidence | Young Adult | Contrast Media - adverse effects | Aged, 80 and over | Adult | Female | Child | Nephrogenic Fibrosing Dermopathy - epidemiology | Meglumine - adverse effects | Organometallic Compounds - adverse effects | Risk Factors | Nephrogenic Fibrosing Dermopathy - chemically induced | Europe - epidemiology | Magnetic Resonance Imaging | Asia - epidemiology | Internationality | Adolescent | Aged | Medicine, Experimental | Medical research | Nausea | Safety and security measures | Contrast media | Rodents | Creatinine | Kidneys | Identification methods | Urticaria | Central nervous system | Nervous system | Risk analysis | Patients | Risk factors | Glomerular filtration rate | Demographics | Renal insufficiency | Magnetic resonance imaging | Vomiting | Fibrosis | Adults | Children | Safety | Age | Kidney transplantation | Original Research
Journal Article
European Radiology, ISSN 0938-7994, 5/2013, Volume 23, Issue 5, pp. 1250 - 1259
Journal Article
Academic Radiology, ISSN 1076-6332, 10/2019, Volume 26, Issue 10, pp. e284 - e291
Previous studies on possible accumulation of gadolinium-based contrast agents (GBCA) in the brain suggest that macrocyclic GBCA are less likely to accumulate... 
Macrocyclic gadolinium-based contrast agents | Dentate nuclei | Globus pallidus | Gadoterate-meglumine | Multiple sclerosis | Analysis
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Investigative Radiology, ISSN 0020-9996, 2017, Volume 52, Issue 7, pp. 396 - 404
Journal Article
European Journal of Radiology, ISSN 0720-048X, 07/2014, Volume 83, Issue 7, pp. 1245 - 1249
To retrospectively compare a reduced dose (RD) (0.075 mmol/kg) of gadobenate dimeglumine (RD-gadobenate) with standard single dose (SSD) (0.1 mmol/kg) of... 
Gadoterate meglumine | Contrast material dose | Brain MRI | Gadobenate dimeglumine | Contrast-enhanced MRI | Magnetic resonance imaging | Analysis
Journal Article